Association of Cancer and the Risk of Developing Atrial Fibrillation: A Systematic Review and Meta-Analysis.


Journal

Cardiology research and practice
ISSN: 2090-8016
Titre abrégé: Cardiol Res Pract
Pays: United States
ID NLM: 101516542

Informations de publication

Date de publication:
2019
Historique:
received: 05 08 2018
revised: 18 02 2019
accepted: 03 03 2019
entrez: 22 5 2019
pubmed: 22 5 2019
medline: 22 5 2019
Statut: epublish

Résumé

Previous studies have demonstrated epidemiological evidence for an association between cancer and the development of new-onset atrial fibrillation (AF). However, these results have been conflicting. This systematic review and meta-analysis was conducted to examine the relationship between cancer and the risk of developing atrial fibrillation. PubMed and Web of Science were searched for publications examining the association between cancer and atrial fibrillation risk published until June 2017. Adjusted odds ratios (ORs) or hazard ratios (HRs) and 95% CI were extracted and pooled. A total of five studies involving 5,889,234 subjects were included in this meta-analysis. Solid cancer patients are at higher risk developing atrial fibrillation compared to noncancer patients (OR 1.47, 95% CI 1.31 to 1.66, The risk of AF was highest within 90 days of cancer diagnosis. We should take into account the increased risk of atrial fibrillation development and, after this, study the embolic risk and potential indication of oral anticoagulation.

Identifiants

pubmed: 31110819
doi: 10.1155/2019/8985273
pmc: PMC6487146
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

8985273

Références

Circulation. 2001 Dec 11;104(24):2886-91
pubmed: 11739301
Am J Med. 2002 May;112(7):587-8
pubmed: 12015256
Anticancer Res. 2002 Mar-Apr;22(2B):1289-93
pubmed: 12168939
Circulation. 2002 Aug 27;106(9):e40; author reply e40
pubmed: 12196350
Recenti Prog Med. 2003 Jun;94(6):260-3
pubmed: 12793097
Circulation. 2003 Dec 16;108(24):3006-10
pubmed: 14623805
JAMA. 2004 Feb 4;291(5):585-90
pubmed: 14762037
World J Surg Oncol. 2004 Nov 29;2:40
pubmed: 15569387
Ital J Neurol Sci. 1992 Mar;13(2):125-9
pubmed: 1592572
An Med Interna. 2006 Jun;23(6):295-6
pubmed: 17078156
J Am Coll Cardiol. 2007 Apr 17;49(15):1642-1648
pubmed: 17433956
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Heart Rhythm. 2008 Feb;5(2):215-21
pubmed: 18242542
Intern Emerg Med. 2008 Sep;3(3):227-31
pubmed: 18320149
Cell. 2010 Mar 19;140(6):883-99
pubmed: 20303878
Eur J Epidemiol. 2010 Sep;25(9):603-5
pubmed: 20652370
J Emerg Med. 2012 Mar;42(3):312-3
pubmed: 20851556
South Med J. 2011 Sep;104(9):667-8
pubmed: 21886091
Intern Emerg Med. 2012 Oct;7(5):431-8
pubmed: 21968511
Isr Med Assoc J. 2011 Oct;13(10):635-7
pubmed: 22097236
Mayo Clin Proc. 2012 Feb;87(2):e9
pubmed: 22305039
Int J Cardiol. 2013 May 10;165(2):355-7
pubmed: 22989607
J Am Coll Cardiol. 2012 Dec 4;60(22):2263-70
pubmed: 23194937
Int J Cardiol. 2013 Sep 1;167(5):1807-24
pubmed: 23380698
P R Health Sci J. 2013 Mar;32(1):14-7
pubmed: 23556261
J Chin Med Assoc. 2014 Mar;77(3):117-21
pubmed: 24332415
Circulation. 2014 Feb 25;129(8):837-47
pubmed: 24345399
J Am Coll Cardiol. 2014 Mar 18;63(10):945-53
pubmed: 24361314
Neth Heart J. 2014 Oct;22(10):472-3
pubmed: 24842374
Front Horm Res. 2014;43:45-56
pubmed: 24943297
Herz. 2015 Apr;40 Suppl 2:101-9
pubmed: 24990773
PLoS One. 2014 Aug 13;9(8):e102861
pubmed: 25119880
Am J Cardiol. 2015 Apr 15;115(8):1090-4
pubmed: 25711434
J Thorac Dis. 2015 Feb;7(2):193-8
pubmed: 25713736
PLoS One. 2015 Aug 28;10(8):e0135609
pubmed: 26317627
Int J Cardiol. 2016 Sep 15;219:186-94
pubmed: 27327505
Int J Cardiol. 2016 Oct 1;220:837-41
pubmed: 27394984
JAMA Cardiol. 2016 Jul 1;1(4):384-6
pubmed: 27438312
JAMA Cardiol. 2016 Jul 1;1(4):389-96
pubmed: 27438314
Front Physiol. 2016 Aug 03;7:313
pubmed: 27536244
JAMA Cardiol. 2017 Mar 1;2(3):343-344
pubmed: 27851852
Am J Epidemiol. 2017 Mar 1;185(5):372-384
pubmed: 28174828
Gene. 2018 Feb 5;642:26-31
pubmed: 29126922
Torace. 1974 Jun;17(1-2):310-25
pubmed: 4465987
Dig Dis Sci. 1994 Nov;39(11):2480-4
pubmed: 7956619
Lik Sprava. 1995 Jul-Aug;(7-8):128-30
pubmed: 8846348
Clin Sci (Lond). 1998 Sep;95(3):347-54
pubmed: 9730855

Auteurs

Ming Yuan (M)

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.

Zhiwei Zhang (Z)

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.

Gary Tse (G)

Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, SAR, China.
Li Ka Shing Institute of Health Sciences, 30-32 Ngan Shing St, Chinese University of Hong Kong, Hong Kong, SAR, China.

Xiaojin Feng (X)

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.

Panagiotis Korantzopoulos (P)

First Department of Cardiology, University Hospital of Ioannina, Ioannina, Greece.

Konstantinos P Letsas (KP)

Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, Evangelismos General Hospital of Athens, Athens, Greece.

Bryan P Yan (BP)

Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, SAR, China.
Department of Epidemiology and Preventive Medicine, Monash University, Clayton, Australia.

William K K Wu (WKK)

Department of Anaesthesia and Intensive Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.

Huilai Zhang (H)

Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.

Guangping Li (G)

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.

Tong Liu (T)

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.

Yunlong Xia (Y)

Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, China.

Classifications MeSH